Navigation Links
Malaria No More and Sumitomo Chemical Help Protect 1.4 Million Kids from Malaria
Date:10/18/2007

All Children Under 5 in Madagascar to Sleep Under Bed Nets

NEW YORK, Oct. 18 /PRNewswire-USNewswire/ -- Malaria No More and Sumitomo Chemical have teamed up to contribute to the distribution of 1.4 million bed nets to children in Madagascar between October 22-29.

Led by the Malagasy government, the campaign will ensure that virtually every child aged six months to five years old receives a bed net. Sumitomo Chemical donated 110,000 long-lasting insecticide-treated Olyset nets to the distribution. Through the support of Idol Gives Back and The Charity Projects Entertainment Fund, Malaria No More is funding education, distribution, and logistical support associated with the nets. Additional partners in the campaign include the U.S. President's Malaria Initiative, UNICEF, and Red Cross of America and Canada.

Malaria kills more African children than any other disease -- approximately 3,000 every day. It is endemic to 90 percent of Madagascar, where it is the number one cause of death among children. Madagascar's under-5 mortality rate, 124 deaths for every 1,000 live births, is more than 15-times that of the United States.

"Malaria imposes a terrible cost on the lives and livelihoods of people in Madagascar," said Scott Case, COO of Malaria No More. "A $10 long-lasting insecticide-treated bed net is often all it takes to save a child's life."

Sumitomo Chemical's revolutionary Olyset technology has transformed malaria control by incorporating insecticide into the fibers of nets, ensuring that they remain effective for at least five years. Olyset nets are tear-resistant, wash-proof, and never require treatment, making them ideal for difficult-to-reach regions like Madagascar's Central Highlands regions where they will be distributed this week.

"The real test of any bed net is malaria prevention," said Tatsuo Mizuno, General Manager of Vector Control in Sumitomo Chemical's Environmental Health Division. "The extreme durability of Olyset nets will protect the Central Highlands residents for a minimum of five years."

The bed net distribution is part of an integrated Measles Initiative campaign that will also distribute measles and polio vaccines, Vitamin A supplements, and de-worming pills to children. According to a recent UNICEF report, child mortality has reached a record low, dropping below 10 million deaths worldwide (to 9.7 million), down from almost 13 million in 1990. Efforts to combat malaria and measles have played a significant role in that decline.

ABOUT MALARIA NO MORE

Malaria No More's mission is simple: to end deaths due to malaria. The world has known how to beat this disease for more than a century, yet it remains the number one killer of children under five in Africa, claiming more than 1 million lives a year. Malaria No More works to raise the profile of the disease among the public, policymakers, and businesses, while engaging the private sector to provide life-saving bed nets and other critical interventions to families in Africa.

ABOUT SUMITOMO CHEMICAL

Sumitomo Chemical is a multi-national Japanese company, with decades of experience in insecticide manufacturing and plastics technology. Dedicated to solving environmental and social problems through innovative technology and sustainable development, Sumitomo Chemical believes the cycle of poverty can be broken by the prevention of vector-borne diseases. As Olyset has been proven to be the most cost-effective malaria intervention today, Sumitomo Chemical is working to ensure this technology reaches those in need through provision of donated or low-cost nets, and through participation in a 50/50 joint venture for local African manufacture of Olyset.

FOR MORE INFORMATION:

MALARIA NO MORE

Martin Edlund

+1 917 224 3563

martin.edlund@malarianomore.org

SUMITOMO CHEMICAL

Seth Amgott

Office: + 1 212 595 3670

Mobile: + 1 202 415 2625

seth@amgottmitchell.com


'/>"/>
SOURCE Malaria No More
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Feeding channel created by malaria parasite - a new target for malaria treatments
2. Hundred million dollar gift for malaria institute
3. Malaria strikes Munger tribals
4. Sponging Cattle betters spraying in eradicating Malaria
5. Misleading anti-malarial drug
6. Garlic fights malaria and cancer
7. Gene researchers make Malaria-resistant mosquito
8. More Treatment Options For Malaria
9. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
10. New initiative launched to fight malaria by repelling mosquitoes
11. Jharkhand reports 13,000 Malaria cases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... ... a new educational seminar to focus on current legislative activity and the latest ... begin at 1 p.m. Sunday, Sept. 10, and will continue through Monday, Sept. ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of community ... healthiest seniors are located in the Midwest. With the average cost of healthcare rising ... are concerned with both the quality and affordability of where they live. An annual ...
(Date:5/26/2017)... BOSTON, MA (PRWEB) , ... May 26, 2017 , ... ... Care Act (AHCA), which narrowly passed the U.S. House on May 4, would result ... would be expected under continued implementation of the 2010 Patient Protection and Affordable Care ...
(Date:5/26/2017)... ... 2017 , ... Silver Birch of Hammond, a new assisted lifestyle community, has ... acres of land at 5620 Sohl Avenue in Hammond, serves older adults who need ... studio and one-bedroom apartments. Each of the private apartments at Silver Birch features a ...
(Date:5/26/2017)... ... May 26, 2017 , ... “When the Stars Lead Home”: a poignant story ... published author Laura Weigel Douglas, an avid reader who lives in the Pacific Northwest ... feels like Green Hills Adventure Camp. She couldn’t be more grateful. , Twelve-year old ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... May 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of ... Canadian Intellectual Property Office has granted Oramed a ... of Exenatide". The patent covers Oramed,s invention of ... GLP-1 is an incretin hormone that stimulates the ...
(Date:5/6/2017)... , May 5, 2017   Provista , a proven ... than 200,000 customers, today announced Jim Cunniff as ... of executive and business experience to Provista, including most recently ... in California . He assumed his new ... is a great fit for Provista," says Jody Hatcher ...
(Date:5/4/2017)...  A recent study published in the American ... as a means of disinfection anesthesia workstations ... on anesthesia workstations. In the study, UVC disinfection ... equipment surfaces contaminated with three (3) organisms commonly ... further validates the body of literature supporting Tru-D," ...
Breaking Medicine Technology: